Presentations and Abstracts: Workshop on Pharmaceuticals in the Environment
You will need Adobe Acrobat Reader, available as a free download, to view some of the files on this page. See EPA's PDF page to learn more about PDF, and for a link to the free Acrobat Reader.
Last Name First Name Abstract Presentation
Alwan
Al
Managing Emerging Contaminants: A Practical Approach (PDF , 23pp., 96KB)
Session I- Wednesday Morning - Chemistry [No abstract submitted]
(PDF , 4pp., 26KB)
Armbrust
Kevin
Occurrence, Environmental Fate, and Exposure Assessment of Selective Serotonin Reuptake Inhibitors (SSRIs) in Aquatic Environments (PDF , 28pp., 721KB)
Armstrong
Jeffrey
Wastewater Treatment Plant Perspectives: Preliminary Data Suggesting Endocrine Disruptor Effects of Wastewater Discharge into the Pacific Ocean (PDF , 19pp., 832KB)
Benotti
Mark
Occurrence and Fate of High-Volume Pharmaceuticals in Wastewater-Impacted Environments (PDF , 24pp., 1.02MB)
Bisceglia
Kevin
Pharmaceuticals and Personal Care Products as Environmental Contaminants (1): Preliminary Environmental Risk Calculations and Method Development for Analysis in Environmental Media via GC/MS [Presentation not available]
Black
Marsha
Endocrine Effects of Selective Serotonin Reuptake Inhibitors (SSRIs) on Aquatic Organisms (PDF , 34pp., 1010KB)
Overview of a Framework for Assessing the Hazards of Human Pharmaceuticals in the Environment From a SETAC Pellston Workshop (PDF , 21pp., 146KB)
Brownawell
Bruce
Detection and Fate of Environmental Estrogens in Wastewater-Impacted Surface and Groundwaters [Presentation not available]
Buzby
Mary
Perspectives From the Pharmaceutical Industry (PDF , 32pp., 613KB)
Conerly
Octavia
EPA Regulatory Authority and EPA Regulatory Authority and PPCPs PPCPs [No abstract submitted]
(PDF , 16pp., 113KB)
Daughton
Christian
Overview of Science Involved with Pharmaceuticals [No abstract submitted]
(PDF , 59pp., 2.75MB)
U.S. EPA Workshop:Pharmaceuticals in the Environment [No abstract submitted]
(PDF , 7pp., 592KB)
Davis
J.C.
Conveying Risk and Progress: Communicating With the Public About Pharmaceuticals in Drinking Water (PDF , 19pp., 658KB)
Eirkson
Charles
Environmental Assessment for Pharmaceuticals [No abstract submitted]
(PDF , 32pp., 325KB)
Galvin
David
Washington State and King County’s Perspective on Pharmaceutical Stewardship (PDF , 20pp., 1015KB)
Glassmeyer
Susan
Identifying Chemical Compounds from Wastewater Discharges (PDF , 15pp., 645KB)
Session I- Wednesday Morning - Chemistry [No abstract submitted]
(PDF , 2pp., 17KB)
Graham
David
Mechanisms of Tetracycline Resistance Development in the Environment as Detected by Real-Time PCR [Presentation not available]
Gressitt
Stevan
Maine: First U.S. Legislation for Unused Pharmaceutical Returns (PDF , 36pp., 1.19MB)
Khiari
Djanette
Pharmaceuticals and PCPs GWRC activities [No abstract submitted]
(PDF , 28pp., 278KB)
Session I- Wednesday Morning - Biology [No abstract submitted]
(PDF , 5pp., 27KB)
Kibbey
Tohren
Adsorption of Beta-Blocker Anti-Hypertensive Pharmaceuticals to a Range of Mineral Surfaces [Presentation not available]
Knapp
Charles
Fate, Attenuation, and Effects of Fluoroquinolone Antibacterials in Aquatic Systems [Presentation not available]
Kostich
Mitchell
An Informatic Approach to Estimating Ecological Risks Posed by Pharmaceutical Use (PDF , 13pp., 356KB)
O'Connor
Catherine
The Metropolitan Water
Reclamation District of Greater Chicago’s Efforts To Reduce
Pharmaceuticals That Enter the Water Reclamation Plants (PDF , 15pp., 440KB)
Page
Angela D.
Overview of the U.S. EPA’s ORD and STAR Program [No abstract submitted]
(PDF , 18pp., 805KB)
Rubinstein
Lynn
Collecting Unwanted Medications for Appropriate Disposal (PDF , 23pp., 326KB)
Seeger
Vickie
Perspectives From the DEA on What Can and Cannot Be Done Via Drug Take-Back Programs (PDF , 10pp., 241KB)
Smith
Bobbye
The EPA Regional Perspective – Why Pharmaceuticals in the Environment are an Emerging Science Issue to EPA’s Regions [No abstract submitted]
(PDF , 14pp., 217KB)
Session I- Wednesday Morning - Biology [No abstract submitted]
(PDF , 3pp., 25KB)
Session I- Wednesday Afternoon - Barriers to Moving Forward [No abstract submitted]
(PDF , 7pp., 34KB)
Smith
Charlotte
Environmental Stewardship of Waste Pharmaceuticals From a Hospital Perspective (PDF , 61pp., 1.67MB)
Tietge
Joseph E.
Overview of ORD's Aquatic
Toxicology Research on Endocrine-Active Chemicals [Presentation not available]
Weinberg
Howard
Occurrence and Fate of Antibiotics and Other Pharmaceutically Active Compounds During Transport to and During Drinking Water Treatment [Presentation not available]
Wen
Chen
Session II- Wednesday Afternoon - Policy [No abstract submitted]
(PDF , 5pp., 29KB)
The Programmatic and/or Regulatory Constraints to Reducing Pharmaceuticals in the Environment [No abstract submitted]
(PDF , 4pp., 25KB)
Yu
Jim
Pharmaceuticals and Personal Care Products as Environmental Contaminants (2): Biodegradability Studies and Occurrence in Sewage Treatment Plant Influent and Effluent [Presentation not available]
